TAVI for pure aortic regurgitation with a dedicated CE-mark device: an underdiagnosed and undertreated disease

Sponsored by JenaValve Technology
TAVI
Symposium
Room 3

Anchorperson: Andreas Baumbach

Spokesperson: Dan Blackman

Discussants: Mohamed Abdel-Wahab, Madalina Garbi, Hendrik Treede

Watch this session if you want

  • To learn how to improve the treatment of aortic regurgitation, a disease that is underdiagnosed and undertreated
  • To learn about TAVI for aortic regurgitation
  • To explore the future of TAVI for aortic regurgitation
Welcome and session objectives

Andreas Baumbach

Aortic regurgitation: unmet needs

Madalina Garbi

Discussion and audience interaction
Performance of a dedicated TAVI device for aortic regurgitation

Hendrik Treede

Discussion and audience interaction
TAVI for aortic regurgitation – Where we are now and what the future holds

Mohamed Abdel-Wahab

Discussion and audience interaction
Session evaluation and key learnings

Dan Blackman